What will the future of cancer treatment look like?

---

MRNA CANCER VACCINE

A “personalised” cancer vaccine developed by Moderna and Merck has achieved what they describe as a “major milestone in the fight against cancer” – becoming the first mRNA-based cancer therapy to report “positive results” from a Phase 3 clinical trial.

The “treatment”, known as Intismeran Autogene, is “designed specifically for each patient’s tumour”. Rather than being a conventional vaccine that prevents, it is intended to “train the immune system to recognise and attack cancer cells that may remain after surgery”.

The ‘breakthrough’ uses technology similar to that behind COVID-19 vaccines.

However, instead of teaching the immune system to ‘recognise a virus’, the cancer vaccine works by analysing genetic material from a patient’s tumour and identifying mutations that distinguish cancer cells from healthy cells.

In the Phase 3 INTerpath-001 trial, 1,137 people with high-risk melanoma – whose tumours had been removed through surgery – received either the personalised vaccine alongside Merck’s immunotherapy pembrolizumab, or pembrolizumab alone.

The trial reportedly met its primary endpoint of “recurrence-free survival”, meaning patients receiving the combination went longer without their cancer returning.

It also met a key secondary endpoint measuring distant metastasis-free survival – the length of time before cancer spread to other parts of the body.

The findings represent the first ever ‘positive’ Phase 3 result for an individualised neoantigen therapy and an mRNA-based cancer treatment.

A ‘personalised mRNA treatment’ can then be “designed”, they say, to “produce signals” that help the immune system recognise cancer-specific targets.

Each vaccine is “tailored” to an individual patient’s tumour.

There is also an important caveat to the latest announcement. The companies have released topline results showing that the trial met its key endpoints, but the complete clinical data has not yet been published in a peer-reviewed medical journal.

Detailed results, including longer-term evidence about overall survival, are still awaited.

Nonetheless, Moderna’s stocks have skyrocketed earlier this month – more than doubling to $140.12 a share after it announced initial results.

The companies hope the results will eventually lead to regulatory approval and potentially open the door to a new generation of ‘personalised cancer treatments’.

An open door that will unleash a plethora of new ‘therapeutic’ mRNA products.

In the near future, everything we once knew as a ‘vaccine’ will be replaced entirely with mRNA technology, as the evolution is supercharged with each passing year.

Whatever the ailment or illness, there will soon be a biological mRNA jab for it.

THE FUTURE OF VACCINES

The development comes as researchers investigate whether mRNA vaccines could be used against other cancers, including lung, bladder, kidney, pancreatic, stomach, and more.

For instance, multiple hospitals across Australia have run trials to develop ‘personalised’ mRNA brain tumour jabs for children, with similar aims of ‘targeting’ and ‘attacking’.

Australia to launch trials of ‘personalised’ mRNA jabs for childhood brain cancer
RELATED ARTICLE

However, despite the ‘advancements’ of vaccines and other modern medical practices, humans seem to still be getting sicker, weaker, and more prone to disease and illness.

Cancer itself still seems to remain ‘unsolved’, despite hundreds of billions of dollars being poured into research to find a ‘cure’ each year – all by design.

For instance, it has recently been revealed that Australia now records some of the highest rates of aggressive bowel cancer in the world for those aged under 50.

Why Does Australia Now Have the World’s Highest Rate of Bowel Cancer Under 50?
RELATED FEATURE

Women under 50 in the United States are also now diagnosed with cancer at rates around 82 per cent higher than men of the same age, according to the latest data.

U.S cancer diagnoses in young women outpace young men by 82%
RELATED ARTICLE

Some research even suggests that cancers are being caused by the very same medical industry that is offering the mRNA ‘solution’ to the problem.

CT scans could be triggering an alarming number of cancer cases
RELATED ARTICLE

Do you really believe a vaccine developed by these people is here to help?

Humanity is already subjected to enough cancer-linked “forever chemicals” in everything from food, to water, to the air around us that we breathe in.

Cancer-linked ‘forever chemicals’ detected in Sydney water catchments
RELATED ARTICLE

Now the ‘cure’ is being offered by those responsible for the problem in the first place?

Beyond cancer, they hope mRNA  technology will become the default model of vaccine development for every other ‘disease’ as well, including influenza, RSV, and more.

New mRNA jab for urinary infections in the pipeline for Australia
RELATED ARTICLE

‘Universal’ mRNA flu vaccine clinical trials begin
RELATED ARTICLE

Scientists who are already helping to develop ‘dissolvable vaccine patches’ for the world are now also looking for ways to combine mRNA technology with the ‘delivery method’.

Australian researchers advance dissolvable mRNA vaccine patch technology
RELATED ARTICLE

This is precisely why the Australian government recently passed legislation broadening the legal definition of a “vaccine” to include ‘preventative products’ that ‘confer protection through passive immunity’ – to allow for the addition these release.

Why Did Parliament Broaden the Legal Definition of “Vaccine”?
RELATED FEATURE

Good luck to those who try to find out exactly what is associated with them, after the TGA announced they would drop the requirement for safety information to be included in packaging for injectable products administered by healthcare professionals.

New dubious changes for vaccine information in Australia
RELATED ARTICLE

I feel sorry to those who will be subjected to these experimental jab ‘therapies’, especially the children, who will have one hell of a ‘personalised experience’, that’s for sure.

It won’t be long before we see this ‘cancer jab’ on the shelves, along with many other mRNA concoctions to follow them – unleashed on the human population.

I, for one, will be steering as far away as possible from them.

How about you?

---

---

KEEP UP-TO-DATE

For more TOTT News:

Facebook — Facebook.com/TOTTNews

YouTube — YouTube.com/TOTTNews

Instagram — Instagram.com/TOTTNews

Twitter — Twitter.com/EthanTOTT

Rumble — Rumble.com/c/TOTTNews

Bitchute — Bitchute.com/TOTTNews

Gab — Gab.com/TOTTNews

---

---